Gene · 3274
Papers2,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma. | Technol Cancer Res Treat | 2022 | 35730194 | PubTator, text mining | PubMed |
| Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies. | ACS Omega | 2022 | 35721972 | PubTator, text mining | PubMed |
| Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder. | Front Pharmacol | 2022 | 35721194 | PubTator, text mining | PubMed |
| Neuronal differentiation pathways and compound-induced developmental neurotoxicity in the human neural progenitor cell test (hNPT) revealed by RNA-seq. | Chemosphere | 2022 | 35700809 | PubTator, text mining | PubMed |
| The secretome of irradiated peripheral blood mononuclear cells attenuates activation of mast cells and basophils. | EBioMedicine | 2022 | 35671621 | PubTator, text mining | PubMed |
| Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes. | Front Endocrinol (Lausanne) | 2022 | 35669692 | PubTator, text mining | PubMed |
| Histamine via histamine H1 receptor enhances the muscarinic receptor-induced calcium response to acetylcholine in an enterochromaffin cell model. | Clin Exp Pharmacol Physiol | 2022 | 35652717 | PubTator, text mining | PubMed |
| Desensitization Protocol to Carboplatin: A Technical Report. | Cureus | 2022 | 35651423 | PubTator, text mining | PubMed |
| Identification of hub pathways and drug candidates in gastric cancer through systems biology. | Sci Rep | 2022 | 35650297 | PubTator, text mining | PubMed |
| Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. | Arch Toxicol | 2022 | 35648190 | PubTator, text mining | PubMed |
| Potential Targets for Deprescribing in Medically Complex Older Adults with Suspected Cognitive Impairment. | Geriatrics (Basel) | 2022 | 35645282 | PubTator, text mining | PubMed |
| Stem cell-mediated angiogenesis in skin tissue engineering and wound healing. | Wound Repair Regen | 2022 | 35638710 | PubTator, text mining | PubMed |
| Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy. | Int J Biol Sci | 2022 | 35637973 | PubTator, text mining | PubMed |
| Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction. | Cells | 2022 | 35626681 | PubTator, text mining | PubMed |
| Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. | Mol Biomed | 2022 | 35593963 | PubTator, text mining | PubMed |
| Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma. | Aging (Albany NY) | 2022 | 35587368 | PubTator, text mining | PubMed |
| Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm. | Mol Med | 2022 | 35578169 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders. | J Tissue Eng | 2022 | 35570845 | PubTator, text mining | PubMed |
| Molecular Biology of Histamine System, Volume 1. | Int J Mol Sci | 2022 | 35563417 | PubTator, text mining | PubMed |
| Inhibitors of SARS-CoV-2 PLpro. | Front Chem | 2022 | 35559224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3274/papers?page=14